Sign in
Taking people in United StatesNo phase

Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury

Key facts

Who runs it
University of Texas Southwestern Medical Center
Where
Dallas, United StatesSee the 2 sites
Trial code
Status
Recruiting
People taking part
42 people, planned
Started
11 Feb 2025
Expected to end
11 Feb 2027
Type of study
Interventional
Treatments tested
  • Sparrow Ascent Transcutaneous Auricular Neurostimulation (tAN)
Record updated
30 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Post-resuscitation GCS score 12 or below and acute trauma-related intradural blood on head CT scan after TB
  • Age 18 years or older (pediatric trauma patients are not routinely transported to Parkland)
  • Consent from legally authorized representative

Who cannot take part

  • Unclear neurological status because of paralytic medications or intoxication with ethanol or other drugs
  • Abnormal ear anatomy or ear infection
  • Hemodynamic instability
  • Expected imminent mortality because of overwhelming neurological and/or systemic injury
  • Presence of other electrical stimulation devices (pacemaker, cochlear prosthesis, neurostimulator, etc.)
  • Participant is pregnant or lactating
  • Any other significant medical or psychosocial problems that, in the opinion of the investigator, would potentially cause harm to the participant, impact their ability to participate, or influence the results of the trial

This trial is currently available in United States.

  • Parkland Health & Hospital SystemDallas, United StatesContact: Alex Valadka, MDTaking people
  • UT Southwestern Medical CenterDallas, United StatesContact: Alex Valadka, MDTaking people

About the trial

What the trial wants to find out

The overarching goal of this pilot study is to assess the feasibility and safety of transcutaneous auricular neurostimulation (tan) in ICU patients with TBi and to determine the effect of tan on serum markers of inflammation. exploratory analyses will examine effects on such physiological parameters as blood pressure, heart rate, and intracranial pressure (iCP), as well as measures of neurological function.

The group in the trial

  • Determine the effect of tAN on serum concentrations of inflammatory mediators in TBI patientsTreatment being tested

    Subjects will receive treatment upon providing informed consent and will undergo transcutaneous auricular neurostimulation (tAN) once daily during their ICU stay, with the treatment duration not exceeding 10 days. Two blood samples will be collected daily: one before the tAN session and another two hours after the session. Participant data will be collected daily throughout the ICU stay. Additionally, surveys will be collected from registered nurses providing direct care to TBI patients enrolled in the tAN-TBI study to assess the compatibility of tAN with patient care processes in the ICU.

    Treatment: Sparrow Ascent Transcutaneous Auricular Neurostimulation (tAN)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Delivering Transcutaneous Auricular Neurostimulation (tAN) to ICU Patients With Traumatic Brain Injury (tAN-TBI)
Record updated
30 September 2026